about
Structure of the GAF domain, a ubiquitous signaling motif and a new class of cyclic GMP receptorGenerating recombinant anti-idiotypic antibodies for the detection of haptens in solution.Vascular endothelium is critically involved in the hypotensive and hypovolemic actions of atrial natriuretic peptideAlterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertensionA genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy.A genetic model defines the importance of the atrial natriuretic peptide receptor (guanylyl cyclase-A) in the regulation of kidney function.Conditional and targeted overexpression of vascular chymase causes hypertension in transgenic mice.Protein kinase G-I deficiency induces pulmonary hypertension through Rho A/Rho kinase activation.Effect of cyclic stretch on alpha-subunit mRNA expression of Na+-K+-ATPase in aortic smooth muscle cells.A cGMP-dependent protein kinase assay for high throughput screening based on time-resolved fluorescence resonance energy transfer.Androgen-mediated induction of the kidney arachidonate hydroxylases is associated with the development of hypertension.Guanylin and its lysine-containing analogue in the isolated perfused rat kidney: interaction with chymotrypsin inhibitor.Nitric oxide decreases the biological activity of norepinephrine resulting in altered vascular tone in the rat mesenteric arterial bed.Cardiovascular effects of sildenafil in hypertensive men with erectile dysfunction and different alleles of the type 5 cGMP-specific phosphodiesterase (PDE5).Anti-oxidants correct disturbance of redox enzymes in the hearts of rat fetuses with congenital diaphragmatic hernia.Increased renal proximal convoluted tubule transport contributes to hypertension in Cyp4a14 knockout mice.Inositol 1,4,5-Trisphosphate Receptors in Hypertension
P2860
Q24631262-98D7DB72-4905-42FA-B31D-1A6205708949Q30940134-C4E81FC9-72C1-4AFB-99AF-22E742E25367Q33831907-85D50872-D6BE-45D4-8D01-5884D77BF866Q33943987-385A0185-AF7F-480B-AD57-5520B8F0BFB6Q34486162-4F702C16-2D6C-4B28-9F07-AB9761784ED4Q35683344-D797C12B-9996-4B2E-ABD0-E2C88BD7AFE9Q36311525-FC57A191-8519-4838-BC84-A5E40FBBF6A3Q41819469-6827DB7B-5DBB-4781-9A80-755230D06D28Q43606072-EC0167D6-4DA0-49C6-AA96-2A79F10E8DF0Q43786433-B49992B7-652A-4644-A300-1334C05E1E34Q44280897-EF91E0E1-18F5-4B69-A7AC-31A1312CEFB9Q44445224-F602BD40-88DF-4B1B-BF0A-4180347EA699Q44698708-90988769-97E8-47DE-9DB5-6BF109087B16Q44919822-973832F7-E15B-4E5C-AC82-CF9262DBA846Q47871813-EE490B3B-B635-4DD5-953F-2B4DD67B7723Q55052189-9A3977E5-2B3B-48D5-9663-1EF6C7FFDAA3Q57657581-C7B40ECE-1CF0-4950-AC2B-E8374C411003
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The molecular basis of hypertension.
@ast
The molecular basis of hypertension.
@en
type
label
The molecular basis of hypertension.
@ast
The molecular basis of hypertension.
@en
prefLabel
The molecular basis of hypertension.
@ast
The molecular basis of hypertension.
@en
P1476
The molecular basis of hypertension.
@en
P2093
P304
P356
10.1146/ANNUREV.BIOCHEM.68.1.127
P577
1999-01-01T00:00:00Z